Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Effects of surgical treatment for acromegaly on knee MRI structural features.

Nezu M, Kudo M, Morimoto R, Ono Y, Omata K, Tezuka Y, Igarashi Y, Hitachi S, Takase K, Ito S, Satoh F.

Endocr J. 2018 Jul 13. doi: 10.1507/endocrj.EJ18-0108. [Epub ahead of print]

2.

Image quality and radiation dose of low-tube-voltage CT with reduced contrast media for right adrenal vein imaging.

Takahashi Y, Ota H, Omura K, Dendo Y, Otani K, Matsuura T, Kitami M, Seiji K, Tezuka Y, Nezu M, Ono Y, Morimoto R, Satoh F, Takase K.

Eur J Radiol. 2018 Jan;98:150-157. doi: 10.1016/j.ejrad.2017.11.017. Epub 2017 Nov 26.

PMID:
29279155
3.

Reducing Inflammatory Cytokine Production from Renal Collecting Duct Cells by Inhibiting GATA2 Ameliorates Acute Kidney Injury.

Yu L, Moriguchi T, Kaneko H, Hayashi M, Hasegawa A, Nezu M, Saya H, Yamamoto M, Shimizu R.

Mol Cell Biol. 2017 Oct 27;37(22). pii: e00211-17. doi: 10.1128/MCB.00211-17. Print 2017 Nov 15.

4.

Nrf2 inactivation enhances placental angiogenesis in a preeclampsia mouse model and improves maternal and fetal outcomes.

Nezu M, Souma T, Yu L, Sekine H, Takahashi N, Wei AZ, Ito S, Fukamizu A, Zsengeller ZK, Nakamura T, Hozawa A, Karumanchi SA, Suzuki N, Yamamoto M.

Sci Signal. 2017 May 16;10(479). pii: eaam5711. doi: 10.1126/scisignal.aam5711.

PMID:
28512147
5.

Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.

Nezu M, Suzuki N, Yamamoto M.

Am J Nephrol. 2017;45(6):473-483. doi: 10.1159/000475890. Epub 2017 May 13. Review.

6.

Derepression of the DNA Methylation Machinery of the Gata1 Gene Triggers the Differentiation Cue for Erythropoiesis.

Yu L, Takai J, Otsuki A, Katsuoka F, Suzuki M, Katayama S, Nezu M, Engel JD, Moriguchi T, Yamamoto M.

Mol Cell Biol. 2017 Mar 31;37(8). pii: e00592-16. doi: 10.1128/MCB.00592-16. Print 2017 Apr 15.

7.

Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression.

Nezu M, Souma T, Yu L, Suzuki T, Saigusa D, Ito S, Suzuki N, Yamamoto M.

Kidney Int. 2017 Feb;91(2):387-401. doi: 10.1016/j.kint.2016.08.023. Epub 2016 Oct 24.

PMID:
27789056
8.

Activated Intrarenal Renin Angiotensin Systems Is the Primary Source of Progressing Renal Damage in Primary Aldosteronism.

Satoh F, Iwakura Y, Morimoto R, Ono Y, Tezuka Y, Omata K, Nezu M, Igarashi Y, Kudo M, Ito S.

J Am Soc Hypertens. 2016 Jul;10 Suppl 1:e9. doi: 10.1016/j.jash.2016.06.026. No abstract available.

PMID:
27677148
9.

Renal Resistive Index Predicts Postoperative Blood Pressure Outcome in Primary Aldosteronism.

Iwakura Y, Ito S, Morimoto R, Kudo M, Ono Y, Nezu M, Takase K, Seiji K, Ishidoya S, Arai Y, Funamizu Y, Miki T, Nakamura Y, Sasano H, Satoh F.

Hypertension. 2016 Mar;67(3):654-60. doi: 10.1161/HYPERTENSIONAHA.115.05924. Epub 2016 Jan 25.

PMID:
26865201
10.

A case of bilateral aldosterone-producing adenomas differentiated by segmental adrenal venous sampling for bilateral adrenal sparing surgery.

Morimoto R, Satani N, Iwakura Y, Ono Y, Kudo M, Nezu M, Omata K, Tezuka Y, Seiji K, Ota H, Kawasaki Y, Ishidoya S, Nakamura Y, Arai Y, Takase K, Sasano H, Ito S, Satoh F.

J Hum Hypertens. 2016 Jun;30(6):379-85. doi: 10.1038/jhh.2015.100. Epub 2015 Nov 5.

11.

Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism?

Satoh F, Morimoto R, Seiji K, Satani N, Ota H, Iwakura Y, Ono Y, Kudo M, Nezu M, Omata K, Tezuka Y, Kawasaki Y, Ishidoya S, Arai Y, Takase K, Nakamura Y, McNamara K, Sasano H, Ito S.

Eur J Endocrinol. 2015 Oct;173(4):465-77. doi: 10.1530/EJE-14-1161. Epub 2015 Jul 20.

PMID:
26194502
12.

Intra-adrenal Aldosterone Secretion: Segmental Adrenal Venous Sampling for Localization.

Satani N, Ota H, Seiji K, Morimoto R, Kudo M, Iwakura Y, Ono Y, Nezu M, Omata K, Ito S, Satoh F, Takase K.

Radiology. 2016 Jan;278(1):265-74. doi: 10.1148/radiol.2015142159. Epub 2015 Jul 6.

PMID:
26147784
13.

Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling.

Souma T, Nezu M, Nakano D, Yamazaki S, Hirano I, Sekine H, Dan T, Takeda K, Fong GH, Nishiyama A, Ito S, Miyata T, Yamamoto M, Suzuki N.

J Am Soc Nephrol. 2016 Feb;27(2):428-38. doi: 10.1681/ASN.2014121184. Epub 2015 Jun 8.

14.

t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs.

Narita T, Inagaki A, Kobayashi T, Kuroda Y, Fukushima T, Nezu M, Fuchida S, Sakai H, Sekiguchi N, Sugiura I, Maeda Y, Takamatsu H, Tsukamoto N, Maruyama D, Kubota Y, Kojima M, Sunami K, Ono T, Ri M, Tobinai K, Iida S.

Blood Cancer J. 2015 Feb 27;5:e285. doi: 10.1038/bcj.2015.6. No abstract available.

15.

[Renal erythropoietin-producing cells and kidney disease].

Nezu M, Souma T, Yamamoto M.

Nihon Rinsho. 2014 Sep;72(9):1691-700. Review. Japanese.

PMID:
25518424
16.

[Endocrine diseases: progress in diagnosis and treatments. Topics: V. Adrenal cortex; 2. What can we do for the proper diagnosis and treatment of primary aldosteronism?].

Satoh F, Morimoto R, Iwakura Y, Ono Y, Matsuda K, Nezu M, Omata K, Kudo M, Ito S.

Nihon Naika Gakkai Zasshi. 2014 Apr 10;103(4):886-94. Japanese. No abstract available.

PMID:
24908986
17.

Radiation dose rates now and in the future for residents neighboring restricted areas of the Fukushima Daiichi Nuclear Power Plant.

Harada KH, Niisoe T, Imanaka M, Takahashi T, Amako K, Fujii Y, Kanameishi M, Ohse K, Nakai Y, Nishikawa T, Saito Y, Sakamoto H, Ueyama K, Hisaki K, Ohara E, Inoue T, Yamamoto K, Matsuoka Y, Ohata H, Toshima K, Okada A, Sato H, Kuwamori T, Tani H, Suzuki R, Kashikura M, Nezu M, Miyachi Y, Arai F, Kuwamori M, Harada S, Ohmori A, Ishikawa H, Koizumi A.

Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):E914-23. doi: 10.1073/pnas.1315684111. Epub 2014 Feb 24.

18.

Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells.

Matsuda K, Uruno A, Kogure N, Sugawara K, Shimada H, Nezu M, Saito-Ito T, Iki Y, Kudo M, Shimizu K, Sato I, Yoshikawa T, Satoh F, Ito R, Yokoyama A, Rainey WE, Saito-Hakoda A, Ito S, Sugawara A.

Mol Cell Endocrinol. 2014 Mar 5;383(1-2):60-8. doi: 10.1016/j.mce.2013.12.004. Epub 2013 Dec 12.

PMID:
24333837
19.

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer.

Matsubara N, Mukai H, Naito Y, Nezu M, Itoh K.

Asia Pac J Clin Oncol. 2013 Dec;9(4):310-7. doi: 10.1111/ajco.12017. Epub 2012 Nov 6.

20.

Effects of the time intervals between venipuncture and serum preparation for serum peptidome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Umemura H, Nezu M, Kodera Y, Satoh M, Kimura A, Tomonaga T, Nomura F.

Clin Chim Acta. 2009 Aug;406(1-2):179-80. doi: 10.1016/j.cca.2009.06.007. Epub 2009 Jun 9. No abstract available.

PMID:
19520068
21.

[A case of hyperammonemic encephalopathy in a patient with recurrent colon cancer treated with modified FOLFOX6].

Teraishi F, Suzuki T, Nakamoto M, Chikuba A, Nezu M, Shimamura H, Watanabe T, Matsuda T, Takiue T, Chikuba H.

Gan To Kagaku Ryoho. 2009 May;36(5):867-9. Japanese.

PMID:
19461197
22.

Procalcitonin might help in discrimination between meningeal neuro-Behçet disease and bacterial meningitis.

Suzuki N, Mizuno H, Nezu M, Takai Y, Misu T, Kuroda H, Aoki M, Nakashima I, Itoyama Y.

Neurology. 2009 Feb 24;72(8):762-3. doi: 10.1212/01.wnl.0000343046.88848.76. No abstract available.

PMID:
19237707
23.

The isolation and identification of apolipoprotein C-I in hormone-refractory prostate cancer using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Yamamoto-Ishikawa K, Suzuki H, Nezu M, Kamiya N, Imamoto T, Komiya A, Sogawa K, Tomonaga T, Nomura F, Ichikawa T.

Asian J Androl. 2009 May;11(3):299-307. doi: 10.1038/aja.2008.38. Epub 2009 Feb 2.

24.

Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.

Shirai Y, Sogawa K, Yamaguchi T, Sudo K, Nakagawa A, Sakai Y, Ishihara T, Sunaga M, Nezu M, Tomonaga T, Miyazaki M, Saisho H, Nomura F.

Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1824-9.

PMID:
19102401
25.

[Case of Neuro-Behçet disease resembling bacterial meningitis].

Nezu M, Suzuki N, Mizuno H, Takai Y, Misu T, Aoki M, Nakashima I, Itoyama Y.

Rinsho Shinkeigaku. 2008 Oct;48(10):750-3. Japanese.

PMID:
19086433
26.

Cytomegalovirus colitis after systemic chemotherapy in a patient with recurrent colon cancer: a case report.

Teraishi F, Shimamura H, Suzuki T, Nakamoto M, Chikuba A, Nezu M, Kohsaka S, Takiue T, Chikuba H.

J Med Case Rep. 2008 Aug 28;2:289. doi: 10.1186/1752-1947-2-289.

27.

[Marked response to S-1 chemotherapy for para-aortic lymph node metastasis arising from gastric cancer].

Teraishi F, Suzuki T, Nakamoto M, Chikuba A, Nezu M, Shimamura H, Takiue T, Chikuba H.

Gan To Kagaku Ryoho. 2007 Nov;34(11):1857-9. Japanese.

PMID:
18030024
28.

Detection of biomarkers for alcoholism by two-dimensional differential gel electrophoresis.

Wu D, Tomonaga T, Sogawa K, Satoh M, Sunaga M, Nezu M, Oh-Ishi M, Kodera Y, Maeda T, Ochiai T, Nomura F.

Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S67-71.

PMID:
17331169
29.

Role of the genetic polymorphisms in the 5'-flanking region for transcriptional regulation of the human CYP2E1 gene.

Uchimoto T, Itoga S, Nezu M, Sunaga M, Tomonaga T, Nomura F.

Alcohol Clin Exp Res. 2007 Jan;31(1 Suppl):S36-42.

PMID:
17331164
30.

Expression of the fetal-oncogenic fibroblast growth factor-8/17/18 subfamily in human hematopoietic tumors.

Nezu M, Tomonaga T, Sakai C, Ishii A, Itoga S, Nishimura M, Matsuo Y, Tagawa M, Nomura F.

Biochem Biophys Res Commun. 2005 Sep 30;335(3):843-9.

PMID:
16095560
31.

Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy.

Tomonaga T, Matsushita K, Ishibashi M, Nezu M, Shimada H, Ochiai T, Yoda K, Nomura F.

Cancer Res. 2005 Jun 1;65(11):4683-9.

32.

Comparative analyses of four different methods of genotyping ALDH2.

Itoga S, Nanmoku T, Uchimoto T, Sunaga M, Nezu M, Tomonaga T, Harada S, Nomura F.

Alcohol Clin Exp Res. 2004 Aug;28(8 Suppl Proceedings):117S-122S.

PMID:
15318097
33.

Identification of novel and downregulated biomarkers for alcoholism by surface enhanced laser desorption/ionization-mass spectrometry.

Nomura F, Tomonaga T, Sogawa K, Ohashi T, Nezu M, Sunaga M, Kondo N, Iyo M, Shimada H, Ochiai T.

Proteomics. 2004 Apr;4(4):1187-94.

PMID:
15048998
34.

[Postgraduate medical training in laboratory medicine and clinical genetics in Chiba University Hospital].

Nomura F, Nezu M, Tomonaga T, Sunaga M.

Rinsho Byori. 2003 Oct;51(10):995-1000. Japanese.

PMID:
14653199
35.

Transcriptional activity of the tandem repeat polymorphism in the 5'-flanking region of the human CYP2E1 gene.

Nomura F, Itoga S, Uchimoto T, Tomonaga T, Nezu M, Shimada H, Ochiai T.

Alcohol Clin Exp Res. 2003 Aug;27(8 Suppl):42S-46S.

PMID:
12960506
36.

Identification of the CAB2/hCOS16 gene required for the repair of DNA double-strand breaks on a core amplified region of the 17q12 locus in breast and gastric cancers.

Nezu M, Nishigaki M, Ishizuka T, Kuwahara Y, Tanabe C, Aoyagi K, Sakamoto H, Saito Y, Yoshida T, Sasaki H, Terada M.

Jpn J Cancer Res. 2002 Nov;93(11):1183-6.

37.

[Non-producer Multiple myeloma].

Kashima R, Nezu M, Nakamura T, Uchimaru K.

Nihon Naika Gakkai Zasshi. 2001 Jan 10;90(1):133-5. Japanese. No abstract available.

PMID:
11215461
38.

Primary aldosteronism as a cause of severe postpartum hypertension in two women.

Nezu M, Miura Y, Noshiro T, Inoue M.

Am J Obstet Gynecol. 2000 Mar;182(3):745-6.

PMID:
10739546
39.

Deletion of the carboxyl-terminal exons of K-sam/FGFR2 by short homology-mediated recombination, generating preferential expression of specific messenger RNAs.

Ueda T, Sasaki H, Kuwahara Y, Nezu M, Shibuya T, Sakamoto H, Ishii H, Yanagihara K, Mafune K, Makuuchi M, Terada M.

Cancer Res. 1999 Dec 15;59(24):6080-6.

40.

On "Transition Dipole Moments for the Vibrational Fundamentals of HNC Determined from the Herman-Wallis Effect"

Nezu M, Amano T, Kawaguchi K.

J Mol Spectrosc. 1999 Nov;198(1):186. No abstract available.

PMID:
10527793
41.

Identification of a novel promoter and exons of the c-ERBB-2 gene.

Nezu M, Sasaki H, Kuwahara Y, Ochiya T, Yamada Y, Sakamoto H, Tashiro H, Yamazaki M, Ikeuchi T, Saito Y, Terada M.

Biochem Biophys Res Commun. 1999 May 19;258(3):499-505.

PMID:
10329415
42.

Transition Dipole Moments for the Vibrational Fundamentals of HNC Determined from the Herman-Wallis Effect.

Nezu M, Amano T, Kawaguchi K.

J Mol Spectrosc. 1998 Nov;192(1):41-46.

PMID:
9770386
43.

Presence of Streptococcus anginosus DNA in esophageal cancer, dysplasia of esophagus, and gastric cancer.

Sasaki H, Ishizuka T, Muto M, Nezu M, Nakanishi Y, Inagaki Y, Watanabe H, Watanabe H, Terada M.

Cancer Res. 1998 Jul 15;58(14):2991-5.

44.

Pure red-cell aplasia requiring cytotoxic chemotherapy: presence of clonal T-lymphocytes without characteristics of chronic lymphocytic leukemia.

Nezu M, Kawano E, Ishii H, Nishimura M, Hirasawa A, Hashimoto S, Morio S, Aotsuka N, Nakamura H, Asai T, Saito Y, Oh H.

Am J Hematol. 1996 Oct;53(2):145-7. No abstract available.

45.

[The combination therapy with vinca-alkaloid slow infusion and cholchicine was effective to refractory idiopathic thrombocytopenic purpura. The patient could receive femoral head replacement in safety].

Nezu M, Oh H, Cho R, Sato H, Ikegami T, Yokota A, Nakaseko C, Nishimura M, Matsuura Y, Morio S, Hiruma K, Nakamura H, Asai T.

Rinsho Ketsueki. 1996 Feb;37(2):158-60. Japanese.

PMID:
8852035
46.

Cell membrane fluidity in K562 cells and its relation to receptor expression.

Iwagaki H, Marutaka M, Nezu M, Suguri T, Tanaka N, Orita K.

Res Commun Mol Pathol Pharmacol. 1994 Aug;85(2):141-9.

PMID:
7994558
47.

Tumour necrosis factor-alpha upregulates transferrin receptors in K 562 cells.

Nezu M, Iwagaki H, Aoki H, Tanaka N, Orita K.

J Int Med Res. 1994 May-Jun;22(3):145-52.

PMID:
8088421
48.

Anti-proliferative effect of combined tumour necrosis factor-alpha and interferon-alpha on human pancreatic cancer in vitro and in vivo.

Watanabe T, Fuchimoto S, Iwagaki H, Nonaka Y, Nezu M, Nishina T, Marutaka M, Susaki K, Naomoto Y, Shiki S, et al.

Anticancer Res. 1993 Sep-Oct;13(5A):1501-5.

PMID:
8239528
49.

Occlusion of a postoperative rectoabdominocutaneous fistula with fibrin clot: a case report.

Iwagaki H, Hizuta A, Nezu M, Nonaka Y, Kimura T, Marutaka M, Kuroda M, Tanaka N, Orita K.

Acta Med Okayama. 1993 Apr;47(2):135-7.

PMID:
8506751
50.

Antitumor activities of IKP-104, a 4(1H)-pyrizinone derivative, on cultured and implanted tumors.

Mizuhashi F, Murata K, Kitagaki T, Nezu M, Sano M, Tomita I.

Jpn J Cancer Res. 1990 Dec;81(12):1300-6.

Supplemental Content

Support Center